0 Yorumlar
0 hisse senetleri
503 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Asia Pacific Alzheimer’s Therapeutics Market Gains Momentum with Growing Healthcare InvestmentAccording to Future Market Insights (FMI), the global Alzheimer’s therapeutics market is projected to expand from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, registering a 9.2% CAGR during the forecast period. The market was valued at USD 3.9 billion in 2025, creating an incremental opportunity of approximately USD 6.5 billion through 2036. Donepezil is expected to account for...0 Yorumlar 0 hisse senetleri 275 Views 0 önizleme
-
Dementia vs. Alzheimer's Disease: What Is the Difference?Dementia and Alzheimer’s disease are often used interchangeably, but they do not mean the same thing. Dementia describes a group of symptoms that affect memory, thinking, communication, and daily activities, while Alzheimer’s is a specific brain disease that commonly causes dementia. Understanding the difference can help families recognize symptoms and seek appropriate medical...0 Yorumlar 0 hisse senetleri 77 Views 0 önizleme
-
How Is Alzheimer’s Treatment Market Advancing with New Drug Innovations?Alzheimer?s Disease Treatment Market Summary: According to the latest report published by Data Bridge Market Research, the Alzheimer?s Disease Treatment Market CAGR Value The global Alzheimer’s Disease Treatment market size was valued at USD 5.50 billion in 2025 and is expected to reach USD 10.79 billion by 2033, at a CAGR of 8.79% during the forecast period The reliable...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
What Are the Most Promising Advances in Alzheimer’s Disease Treatment?According to the latest report published by Data Bridge Market Research, the Alzheimer’s Disease Treatment Market CAGR Value The global Alzheimer’s Disease Treatment market size was valued at USD 5.50 billion in 2025 and is expected to reach USD 10.79 billion by 2033, at a CAGR of 8.79% during the forecast period An influential Alzheimer’s Disease Treatment...0 Yorumlar 0 hisse senetleri 277 Views 0 önizleme
-
Global Neuroprotective Agents Market Growing at 7.1% CAGR Through 2034According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
How to Choose the Right Patient Care Services in Central Delhi and Defence ColonyFinding suitable care for a family member can become difficult when the patient needs regular assistance with everyday activities. Elderly people, individuals recovering after surgery, bedridden patients, and people with limited mobility may require dependable support for bathing, dressing, walking, meals, companionship, and other daily needs. Professional home healthcare provides families...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Investigating Neurological Research and the Expanding Global Rolipram Market ScopeThe human brain remains one of the most complex and heavily studied frontiers in modern medicine. Neurological diseases, cognitive decline, and chronic central nervous system (CNS) disorders present immense challenges to the global healthcare system. In the relentless pursuit of effective treatments, pharmacologists and neuroscientists are intensely focused on cellular signaling pathways and...0 Yorumlar 0 hisse senetleri 715 Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek